Antibiotic Stewardship (ABS). Teil 2: Anwendung

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • S. Wendt - , Leipzig University (Author)
  • D. Ranft - , Leipzig University (Author)
  • K. de With - , Clinical Infectious Disease Unit, University Hospital Carl Gustav Carus Dresden (Author)
  • W. V. Kern - , University of Freiburg (Author)
  • B. Salzberger - , University of Regensburg (Author)
  • C. Lübbert - , Leipzig University (Author)

Abstract

Antibiotic stewardship (ABS) is an important measure to counteract the spread of resistant pathogens and multidrug resistance. The most important ABS tools include the implementation of local guidelines, the development of a house-related list of anti-infective agents, regular ABS visits and practice-oriented internal training events. Effective strategies for therapy optimization include indication testing and therapy evaluation, dose optimization as well as determining an appropriate duration of therapy. Oralization of anti-infectives (sequence therapy) should be supported by consistent clinical criteria in in-house guidelines. The incidence of Clostridioides difficile infections (CDI) can be more than halved by restricting the so-called “4C antibiotics”. Point-of-care tests help to minimize the use of antibiotics in the outpatient setting. Vaccination reduces the need for antibiotic therapy.

Translated title of the contribution
Antibiotic stewardship (ABS). Part 2
Application

Details

Original languageGerman
Pages (from-to)475-486
Number of pages12
JournalDer Internist
Volume61
Issue number5
Publication statusPublished - 1 May 2020
Peer-reviewedYes

External IDs

PubMed 32112153
ORCID /0000-0001-9473-3018/work/148606208

Keywords

Sustainable Development Goals

ASJC Scopus subject areas

Keywords

  • Anti-bacterial agents, Antimicrobial stewardship, Clostridioides difficile, Guidelines, local, Vaccination